ePoster

IDENTIFYING A NEURONAL ROLE FOR THE GENETIC RISK FACTOR <EM>PLCG2</EM> IN ALZHEIMER’S DISEASE

Audrey Coulonand 25 co-authors

Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1167 - RID-AGE

FENS Forum 2026 (2026)
Barcelona, Spain
Board PS05-09AM-211

Presentation

Date TBA

Board: PS05-09AM-211

Poster preview

IDENTIFYING A NEURONAL ROLE FOR THE GENETIC RISK FACTOR <EM>PLCG2</EM> IN ALZHEIMER’S DISEASE poster preview

Event Information

Poster Board

PS05-09AM-211

Abstract

Based on the new genetic landscape of Alzheimer’s disease (AD), we and others proposed that synaptic fragility/sensitivity is a pathological trigger, depending on genetic risk factors. Some of these factors have already been linked to synaptic mechanisms, including BIN1, FERMT2, PTK2B and CD2AP. Within this context, we systematically investigated the potential implications of the genes located in the loci associated with AD risk at synapses. We developed a high content screening to investigate how genetic risk factors for AD may impact synaptic density and function in rat primary neuronal cultures. One of the best hits was the PLCG2 gene. Although PLCG2 has been extensively studied in microglia where it influences the clearance of amyloid plaques, our data suggested that this gene also plays a role at synapses. Consistent impairment of dendritic morphology and synaptic function was found in Plcg2-downregulated mouse dentate gyrus neurons. Genetically, the PLCG2 P522R variant confers protection against AD and is hypermorphic, whereas loss-of-function variants are associated with a 10-fold increase in AD risk. In line with these findings, downregulation of PLCG2 in human induced pluripotent stem cells-derived neurons (hiNs) damaged synapses and increased the levels of Aβ and abnormally phosphorylated Tau. Single-nucleus RNA sequencing and immunoblotting in hiNs confirmed that PLCG2 downregulation impacts pathways related to synaptic and neuronal functions, potentially through neurexins and GSK3β. In conclusion, PLCγ2 downregulation could increase AD risk by impairing synaptic function and increasing the levels of Aβ and abnormally phosphorylated Tau in neurons.

Recommended posters

PLD2 MODULATES LIPID SIGNATURES AND NETWORK EXCITABILITY IN ALZHEIMER’S DISEASE

Tatiana Morais, Luísa Santa-Marinha, Rafaela Morais-Ribeiro, Francisca Vaz Bravo, Marta Mendanha, Cidália Pereira, Inês Ribeiro, Francisco Almeida, Sara Calafate, Tiago Gil Oliveira

IDENTIFICATION OF A FUNCTIONAL VARIANT IN THE ALZHEIMER’S DISEASE GENETIC RISK FACTOR PTK2B

Nina Lannette-Weimann, Ana-Raquel Melo de Farias, Morgane Lemaire, Charlotte Henocq, Audrey Coulon, Pauline Walle, Limoge Floriane, Leo Morita Myakoshi, Angelika Dannert, Judit Gonzalez Gallego, Chloé Najdek, Marcos Costa, Philippe Amouyel, Dominik Paquet, Julien Chapuis, Jean-Charles Lambert, Julie Dumont

FUNCTIONAL EVALUATION OF GENETIC VARIANTS RELATED TO POLYGENIC RISK FOR ALZHEIMER’S DISEASE USING A MASSIVELY PARALLEL REPORTER ASSAY

Danna Perlaza Meneses, Laia Lidón, Alba Cervantes-González, Xuanyang Bai, María Dolores Capilla-López, Esther Álvarez-Sánchez, Natalia Valle-Tamayo, Aleyda Benitez Amaro, Borja Moya-Llamas, Érika Sánchez-Aced, Joaquim Aumatell Escabias, Laia Muñoz, Laura Cervera-Carles, Sònia Sirisi-Dolcet, Oriol Dols-Icardo, Alberto Lleó, Olivia Belbin

LINKING AXONAL PATHOLOGY TO ELN DYSFUNCTION VIA POLYGENIC RISK IN HUMAN TISSUE AND HIPSC MODELS OF ALZHEIMER’S DISEASE

Emily Turschak, Shannon Rose, Kevin Takasaki, Wan-Qing Yu, Steven Cook, Kareena Villalobos, Elizabeth Guadarrama, Russel Torres, Connor Laughland, Eric Perlman, Ayana Hellevik, Souyma Chatterjee, C. Dirk Keene, Jessica Young, R. Clay Reid

IMPACT OF SRC VARIANTS ON ALZHEIMER’S DISEASE

Pauline Walle, Chloé Najdek, Florie Demiautte, Nina Lannette-Weimann, Anne-Marie Ayral, Benjamin Grenier-Boley, Céline Bellenguez, Xavier Hanoulle, Jean-Charles Lambert, Julien Chapuis

ALZHEIMER’S DISEASE RISK FACTOR BIN1: LINKING MICROGLIAL DEFICIENCY TO NEUROINFLAMMATION AND REGULATION OF ADULT HIPPOCAMPAL NEUROGENESIS

Irini Thanou, Maria Margariti, Eirini Portokali, Elsa Papadimitriou, Alexandre Pelletier, Evangelia Xingi, Yassemi Koutmani, Vasiliki Kyrargyri, Marcos Costa, Dimitra Thomaidou

Cookies

We use essential cookies to run the site. Analytics cookies are optional and help us improve World Wide. Learn more.